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Abstract 
Background: Oral diseases pose major public health problems on a global scale. Such diseases have considerable impact on 
individuals and communities by causing pain and suffering, impairment of function and reduced quality of life. The objective 
of this study was to evaluate the antimicrobial activity of five mouthrinses against a variety of microorganisms associated with 
infections of the oral cavity and other body sites.
Methods: Mouthrinse formulations were Chlorhexidine (0.2%), Citrox (1%; Perioplus™)/Hyaluronic acid (0.2%)®, Chlorhexidine 
(0.2%)/Citrox (1%; Perioplus™), Chlorhexidine (0.2%)/Phenoxetol (0.1%)® and Citrox (1%; Oralclens)™ (Oraldent Ltd; UK). The 
test microorganisms were the bacteria, Actinomyces viscosus ATCC 1598; Actinomyces odontolyticus NCTC 9935, Clostridium 
difficile R8651, Prevotella intermedia NCTC 13070T, Prevotella denticola R20771, Porphyromonas gingivalis NCTC 11834T, 
Streptococcus gordonii ATCC 10558T, Streptococcus sanguinis NCTC 7863, and the fungi, Candida albicans ATCC 90028, 
Candida dubliniensis CD36, Candida krusei ATCC 6258, Candida glabrata ATCC 2001, Candida tropicalis ATCC 750 and 
Candida parapsilosis ATCC 22019. Determination of mouthwash antifungal and antibacterial properties was done using a 
microtitre plate assay. In vitro biofilms were constructed using 96-well plates and exposed to a range of mouthrinse concentrations. 
The minimum biofilm eradication concentration (MBEC) was established by examining subsequent re-growth of biofilm cells. 
Results were compared with the minimum inhibitory concentrations (MICs) obtained for planktonic cells cultured in 96-wells 
plates in various mouthrinse concentrations.
Results: Planktonic cells of aerobic microorganisms were inhibited by all mouthrinses at concentrations ≤2% (v/v) of the 
stock preparation. Chlorhexidine (0.2%)/Citrox (1%)™ had the highest antimicrobial activity, followed by Citrox (1%)™, 0.2% 
Chlorhexidine, Chlorhexidine (0.2%)/Phenoxetol (0.1%)® and Citrox (1%)/Hyaluronic acid (0.2%)®. Some anaerobic bacteria 
(Actinomyces odontolyticus, Clostridium difficile, Prevotella intermedia) exhibited higher MICs for all 5 mouthwashes. There was 
a noticeable increase (up to 16-fold) in tolerance to the mouthwashes by the majority of aerobic microorganisms when the  
minimum biofilm eradication concentration was compared to the minimum inhibitory concentration.  
Conclusion: The results highlight enhanced antimicrobial activity using a combined preparation of Chlorhexidine/Citrox 
compared with Chlorhexidine alone.
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Introduction
Dental caries and periodontal diseases are significant health 
problems of humans [1], and arise irrespective of socioeconomic 
class, although they are more prevalent in deprived populations 
[2]. Dental caries affects 60-90% of children in industrialised 
countries [3] and approximately 10-15% of adults are affected 
by severe periodontal disease. These plaque-mediated diseases 
lead to premature dental exfoliation and have a significant 
impact on the quality of life [4,5]. Periodontal disease has 
been also implicated with systemic chronic diseases such as 
cardiovascular disease [6].
An important factor in both caries and periodontal disease 
is the oral microflora and it is the biofilms produced by these 
organisms that are at the centre of disease pathogenesis. 
Thus, biofilm control by mechanical debridement and use of 
adjunctive antimicrobials is of utmost importance in prevention 
of plaque-mediated diseases. Typical adjuncts to oral hygiene 
and prevention of the aforementioned diseases have been the 
use of mouthwashes and toothpastes containing antimicrobial 
components such as triclosan and Chlorhexidine. Both these 
components are classed as biocides as they target multiple 
sites to achieve antimicrobialeffects. Triclosan (5-Chloro-2(2,4-
dichlorophenoxy)phenol) is a halogenated phenol, and a 
non-ionic broad spectrum antimicrobial that has multiple uses 
including being an active component in detergents, clothing, 
toothpastes, and mouthwashes [7]. Concerns regarding 
triclosan use in ‘everyday products’ has been raised, as over 
exposure of microorganisms to this agent might propagate 
resistance and indeed there has been evidence of low-level 
resistance in Staphylococcus aureus [1,8]. Triclosan has also been 
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detected in sediment, soils, and aquatic species [7] and recent 
environmental concerns have been raised leading to some 
calls for its use to be limited [7-11]. Chlorhexidine has also been 
associated with adverse effects including mucositis, altered 
taste, and staining of dental tissues and restorations [1,12]. 
Such undesirable reactions to Chlorhexidine have resulted 
in calls for modified clinical practice [13,14] and along with 
patient preferences have been the drivers for research into 
alternative mouthwashes/remedies for oral care. 
For centuries, plant products have been used as treat-
ments for diseases, and more recently in the development of 
new drugs [13]. Previous studies have indicated the effective 
and efficient use of natural antimicrobials in inhibiting the 
oral microflora [13,14]. Citrox, is a soluble formulation of 
bioflavonoids, derived from citrus fruits, and this agent has 
antimicrobial activity against bacteria, fungi and viruses [15-18].
This present study investigated potential potentiation of 
antimicrobial activity through use of combinations of Citrox 
(1%) with Chlorhexidine (0.2%; Perioplus™), and Citrox (1%)/
Hyaluronic acid (0.2%)®. To this end, reducing Chlorhexidine 
concentration may result in reduced side effects, whilst 
maintaining antimicrobial properties. Hyaluronic acid is a 
major component of collagen, and an important factor in 
wound healing, and thus could be significant in the treatment 
of periodontal disease [19]. Small molecular weight hyaluronic 
acid has also been found to induce expression of toll-like 
receptors, which are important components of the innate 
immune system [20]. Thus, the combination of Citrox with 
hyaluronic acid may provide both bactericidal and wound 
healing properties in vivo. Often, in vitro assessment of 
antimicrobial activity is performed only against planktonic cells, 
and these tend to be much more susceptible to antimicrobials 
than their biofilm counterparts. In this present study, we 
evaluated the antimicrobial activity of 5 different mouthrinses 
against 14 test strains including bacteria and Candida species, 
cultured both planktonically and as biofilms.
Materials and methods
Microorganisms investigated in this studywere Actinomyces 
viscosus (ATCC 1598), Actinomyces odontolyticus (NCTC 9935), 
Clostridium difficile (R865, clinical isolate), Prevotella intermedia 
(NCTC 13070T), Prevotella denticola (R20771), Porphyromona-
sgingivalis (NCTC 11834T), Streptococcus gordonii (ATCC 10558T), 
Streptococcus sanguinis (NCTC 7863), Candida albicans (ATCC 
90028), Candida dubliniensis (CD36 [21]), Candida krusei (ATCC 
6258), Candida glabrata (ATCC 2001) and Candida tropicalis 
(ATCC 750).
The bacteria Actinomyces viscosus ATCC 1598, Actinomy-
cesodontolyticus NCTC 9935, Clostridium difficile R8651, 
Prevotella intermedia NCTC 13070T, Prevotella denticola R20771 
and Porphyromonas gingivalis NCTC 11834T were cultured under 
anaerobic conditions at 37˚C on Fastidious Anaerobe Agar 
(FAA) and in Fastidious Anaerobe Broth (FAB). Streptococcus 
species were cultured aerobically at 37˚C using Blood Agar 
(BA) and Brain Heart Infusion Broth (BHI). Candida species were 
cultured aerobically at 37˚C using Sabouraud Dextrose Agar 
(SDA) and Sabouraud Broth (SAB). All media was obtained 
from Lab M (International Diagnostics Group plc, Bury, UK) 
and prepared as per the manufacturer’s instructions. Broths 
were not adjusted for pH or glucose content. All mouthrinses 
were provided courtesy of Oraldent Limited, UK.
Minimum inhibitory concentration (MIC) determination 
for planktonic cells
Microbial preparations of bacteria and Candida species 
were generated by overnight incubation, and adjusted to a 
turbidity equivalent to a MacFarland standard of 3.0. Serial 
dilutions of the test mouthrinses in the respective culture 
medium were prepared, resulting in a concentration range 
of 0.007% to 8% (v/v) of the parent mouthrinses. A 100-µl 
volume of each test dilution was then combined with 100 µl of 
microbial suspension. Negative controls of broth and bacterial 
suspensions without antimicrobial were also included. To the 
wells of 96-well microtitre plates, 200 µl of the preparations 
were added and incubated for 24 hat 37˚C, under the 
appropriate atmospheric conditions. Following incubation, 
the relative growth of the microbial species was estimated 
by recording the turbidity of wells using spectrophotometric 
absorbance at 620nm. Absorbance readings were standardised 
using ‘microbial-free’ control mouthwash dilutions. The MIC 
was recorded as the lowest concentration of mouthwash 
that showed ≥80% reduction in absorbance compared to 
the controls without mouthrinses.
Minimum Biofilm Eradication Concentrations(MBEC) 
for biofilms
Suspensions of each microorganism (MacFarland standard 
3.0) were incubated in the wells of a flat-bottomedmicrotitre 
plate for 24 h at 37˚C. BHI was used as the culture medium 
for bacteria, FAB was used for culture of anaerobic bacteria 
and SAB for Candida; incubation was without agitation to 
allow formation of a biofilm. The medium was then removed 
by gentle aspiration and the biofilm washed with 100 µl of 
phosphate buffered saline (PBS) to remove planktonic cells. 
Fresh medium containing test mouthrinse concentrations or 
negative control broth was added to the biofilms. Biofilms 
were then incubated for a further 24 h under the described 
conditions. The medium was subsequently removed by gentle 
aspiration and the biofilm washed with PBS. Fresh broth (200 µl) 
was added and the biofilms were disrupted by repeated 
pipetting and agitation. The turbidity of the resuspended 
biofilm was observed by measuring the absorbance at 
620nm. Following a further incubation period of 6 h, the 
absorbance at 620nmwas once again recorded. The relative 
growth of the microorganisms was determined by the 
difference in absorbance over this 6 h period. The mean 
value was calculated from quadruplicate samples in each 
well and the MBEC recorded as the lowest concentration of 
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the test mouthwash that demonstrated a ≥80% reduction in 
absorbance compared to the control. All experiments were 
Minimum inhibitory concentration 
% (v/v)
Mouthrinse A B C D E
Microorganism
C. albicans 1 2 0.5 2 0.5
C. dubliniensis 0.5 1 0.25 2 0.25
C. krusei 0.5 0.5 0.125 0.25 0.125
C. glabrata 0.5 1 0.25 0.5 0.5
C. parapsilosis 0.5 1 0.125 1 0.25
C. tropicalis 0.25 1 0.125 0.25 0.25
S. gordonii 0.5 2 0.25 0.5 1
S. sanguinis 0.5 2 0.25 1 0.5
A. odontolyticus >4 >4 >4 >4 >4
A. viscosus 0.25 0.5 0.125 0.25 0.25
C. difficile >4 >4 >4 >4 >4
P. denticola 4 0.5 0.5 0.5 0.5
P. gingivalis 0.5 1 0.25 0.5 0.5
P. intermedia >4 >4 2 >4 2
Table 1a. Minimum inhibitory concentration % (v/v) of 
mouthrinses against planktonic microorganisms.
Sample A: Chlorhexidine Control (0.2%).
Sample B: Citrox (1%)/Hyaluronic acid (0.2%)®.
Sample C: Chlorhexidine (0.2%)/Citrox (1%)–Perioplus™.
Sample D: Chlorhexidine (0.2%)/Phenoxetol (0.1%)®.
Sample E: Citrox (1%)–Oralclens™.
Minimum Biofilm Eradication  
Concentration % (v/v)
Mouthrinse A B C D E
Microorganism
C. albicans 4 >4 4 >4 2
C. dubliniensis 2 4 2 >4 4
C. krusei 2 1 0.5 2 0.5
C. glabrata 2 4 2 4 4
C. parapsilosis >4 4 1 >4 1
C. tropicalis 2 4 2 4 4
S. gordonii 0.5 2 0.5 1 1
S. sanguinis 0.5 2 0.5 1 1
A. odontolyticus 0.25 1 0.125 0.5 0.25
A. viscosus 0.125 0.25 0.125 0.25 0.125
C. difficile 0.5 4 1 4 1
P. denticola 0.125 1 0.5 0.5 0.5
P. gingivalis 0.125 2 0.25 1 1
P. intermedia 0.25 4 0.063 0.125 0.125
Table 1b. Minimum biofilm eradication concentration % 
(v/v) of mouthrinses against microorganisms grown in 
biofilms.
Sample A: Chlorhexidine Control (0.2%).
Sample B: Citrox (1%)/Hyaluronic acid (0.2%)®.
Sample C: Chlorhexidine (0.2%) / Citrox (1%)–Perioplus™.
Sample D: Chlorhexidine (0.2%)/Phenoxetol (0.1%)®.
Sample E: Citrox (1%)–Oralclens™.
performed on 3 separate occasions. 
Results
Minimum inhibitory concentrations for planktonic growth
of the mouthrinses for the 14 test microorganisms are shown 
in Table 1a. Inhibition of planktonic cells of all aerobic 
microorganisms occurred with the 5 mouthrinses at concen-
trations ≤2% (v/v). Chlorhexidine (0.2%)/Citrox (1%; Perioplus 
™) demonstrated highest antimicrobial activity against aerobic 
microorganisms, followed by Citrox (1%; Oralclens)™, 0.2% 
Chlorhexidine, Chlorhexidine (0.2%)/Phenoxetol (0.1%)® 
and Citrox (1%)/Hyaluronic acid (0.2%)®. For anaerobic 
microorganisms, Actinomyces odontolyticus. Clostridium 
difficile and Prevotella intermedia had relatively high MICs 
against the 5 mouthwashes (≥4% (v/v)). Actinomyces viscosus, 
Prevotella denticola and Porphyromonas gingivalis had MIC 
ranging between 0.125%-1% (v/v).
Minimum Biofilm Eradication Concentrations(MBEC) 
for biofilms
The recorded MBECs in the biofilm assay are shown in Table 1b. 
In the case of aerobic species biofilms, there was a notice-
able increased tolerance (MBEC values of up to 16-fold 
of the previous MIC values) for the majority of the tested 
microorganisms against all 5 mouthrinses formulations. The 
MBECs for anaerobic species were generally lower than for the 
aerobic species. Interestingly, for A. odontolyticus, C. difficile 
and P. intermedia the MBEC was lower than the MIC planktonic 
growth phase, a finding that could indicate relatively poor 
biofilm development.
Discussion
Oral disease is a worldwide health concern having significant 
impact on patient quality of life and function. Of further 
concern is that it is expected that the incidence of dental 
caries and periodontal disease will continue to increase as 
a result of the growing intake of sugars in the diet, tobacco 
use, and inadequate exposure to fluorides, and lack of access 
to dental care [22].
Increasing antibiotic resistance has promoted interest in the 
therapeutic use of non-conventional or alternative medicines 
and plant extracts [13,23-26]. It has been shown that naturally 
occurring biocides are effective in inactivating a variety of 
microorganisms by affecting multiple target sites and are 
therefore less prone to development of resistance compared 
to conventional antibiotics targeting specific bacterial sites 
[27,28]. There is great potential for the development of novel 
bioactive compounds, as there are approximately 500,000 
plant species worldwide, of which only 1% have been phyto-
chemically investigated [29].
Hooper et al., [13] previously tested two Citrox formulations 
against a range of oral microorganisms and reported MICs 
of 1% (v/v) in planktonic and biofilm assays. Extracts from 
Citrus sudachi have also been observed to elicit antimicrobial 
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activity against bacteria, including methicillin-resistant 
Staphylococcus aureus (MRSA) and Helicobacter pylori [16]. 
The relatively high inoculum used in this present study was 
employed to mimic the in vivo challenge of having to combat 
an established high level of microorganisms, as encountered 
in dental plaque, and was based on previous evaluations and 
thus would allow comparisons [13].
The results of this present study demonstrated the anti-
microbial effects of 5 mouthrinse formulations on a range of 
oral microorganisms and C. difficile. Four of these mouthwash 
formulations contained Citrox, which is a combination of 
natural bioflavonoids. Three of these Citrox mouthrinses 
were supplemented with Chlorhexidine, hyaluronic acid or 
phenoxetol.
All test mouthrinses had substantial antimicrobial activity 
against aerobic planktonic microorganisms at concentrations 
≤2% (v/v) with a naerobic species generally less susceptible. 
This activity against planktonic cells is clearly important, as 
free-living microorganisms are abundant in saliva and provide 
the source of bacteria for colonization and subsequent biofilm 
formation on oral surfaces [30,31]. The inhibition of biofilm 
growth is widely recognised as being more problematic than 
that of planktonic cells. The reasons for this are multifactorial 
and complex. It has been suggested that the extracellular 
polymeric substance (EPS) that encases biofilm cells is a key 
component in limiting access of antimicrobial agents to the 
biofilm cells, possibly through charge mediated sequestration 
[32]. Alternatively, the biofilm cells themselves may exhibit 
different phenotypes, and some, may have reduced activity 
due to nutrient or gaseous limitations [33]. Since cells 
with reduced growth rates can be more resistant to many 
antimicrobials, this too could be a reason for enhanced 
tolerance. It was perhaps not surprising therefore to find that 
the antibiofilm activity of the mouthrinses against some 
species was on occasion up to 16-fold higher their planktonic 
counterparts. Surprisingly however, the MBECs of anaerobic 
biofilms were frequently lower compared with the MICs for 
the planktonic counterparts. One caveat to consider was that 
the biofilm growth for anaerobic bacteria was relatively limited 
compared to that of the aerobes and this could explain the 
lower susceptibility compared to their planktonic equivalents. 
Anaerobic species often require nutrient rich media (e.g. FAB) 
for growth compared to aerobes and the former also exhibit 
much slower growth. It may be that the 24 h incubation used 
for biofilm formation was not sufficient for a robust biofilm 
growth of the anaerobes, rendering them more susceptible 
to the mouthrinses. It was also possible that the biofilms 
generated by the anaerobes could also have been less 
stable, which may have led to a loss of biofilm cells during 
the washing steps. To overcome this problem, future studies 
could incorporate longer incubation periods to allow biofilm 
formation and in addition, to incorporate artificial saliva into 
the model system to increase biofilm attachment, as well as 
utilising a more nutrient rich culture medium.
1. Rodrigues JA, Lussi A, Seemann R and Neuhaus KW. Prevention of crown 
and root caries in adults. Periodontol 2000. 2011; 55:231-49. | Article | 
PubMed 
Conclusions
In conclusion, the results suggest that Chlorhexidine (0.2%)/
Citrox (1%; Perioplus™) had highest antimicrobial activity 
and use of this combination formulation was more effective 
than either of its constituent antimicrobial components used 
alone (Citrox or Chlorhexidine). The reason for this finding 
may be indicative of different targets of these antimicrobial 
components leading to an enhanced and possible synergistic 
effect. The mouthrinse, Oralclens™ (1% Citrox) demonstrated 
a slightly higher antimicrobial activity than mouthrinse Citrox 
(1%)/Hyaluronic acid (0.2%)®. Importantly however, previous 
studies have demonstrated that 0.2% hyaluronan-containing 
gel provides benefit as an adjunct to scaling and root planning 
(SRP) in chronic periodontitis patients leading to a significant 
improvement in gingival parameters [34].
Given the reported problems of several over-the-counter 
mouthrinses, such as staining of enamel, burning sensation, 
alterations in taste, and the presence of an alcohol component 
[30,35,36], there is a need for continual development of 
effective mouthrinses to aid oral hygiene regimes. As a result, 
natural compounds such as those incorporated into Citrox 
may be suitable alternatives. Further more, by combining 
Citrox with other supplements as shown in this preliminary 
study, enhanced antimicrobial effects against common oral 
pathogens can be obtained. These findings support further 
investigation into Citrox as a potential future preparation for 
oral care products and potentially other clinical areas where 
biofilms need to be prevented. 
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